| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.5B | $2.5B | $2.3B | $1.0B | $1.8B | $1.7B | $1.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.0B | $-0.2B | $0.2B | $0.1B | $-0.3B | $0.4B | $0.2B | $0.2B |
| Net Income | $-0.0B | $-0.2B | $0.1B | $0.0B | $-0.2B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $-2.48 | $-13.49 | $6.32 | $0.14 | $-11.53 | $14.27 | $10.02 | $11.94 |
| EPS (Diluted) | $-2.48 | $-13.49 | $6.29 | $0.14 | $-11.53 | $14.26 | $10.00 | $11.93 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.2B | $4.4B | $4.9B | $4.5B | $3.3B | $3.0B | $2.5B | $2.2B |
| Current Assets | $1.0B | $1.0B | $1.0B | $1.3B | $0.9B | $0.6B | $0.5B | $0.5B |
| Cash & Equivalents | $0.2B | $0.3B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $3.2B | $3.3B | $3.5B | $3.3B | $2.6B | $2.1B | $1.8B | $1.6B |
| Current Liabilities | $1.0B | $1.3B | $1.2B | $0.9B | $0.7B | $0.6B | $0.5B | $0.6B |
| Stockholders' Equity | $1.1B | $1.1B | $1.3B | $1.2B | $0.7B | $0.9B | $0.7B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.3B | $0.4B | $0.3B | $0.2B | $0.4B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.2B | $0.0B | $-0.7B | $-0.5B | $-0.4B | $-0.5B | $-0.3B | $-0.6B |
| Capital Expenditures | $0.3B | $0.3B | $0.5B | $0.4B | $0.3B | $0.5B | $0.3B | $0.6B |
| Financing Cash Flow | $-0.3B | $-0.2B | $0.2B | $0.0B | $0.2B | $0.1B | $-0.1B | $0.2B |